Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People > = 18 Years Old With Advanced Soft Tissue Sarcoma
Conditions: Metastatic Extraskeletal Myxoid Chondrosarcoma; Metastatic Leiomyosarcoma; Metastatic Liposarcoma; Metastatic Undifferentiated Pleomorphic Sarcoma Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Drug: Cabozantinib; Procedure: Computed Tomography; Biological: Ipilimumab; Procedure: Magnetic Resonance Imaging; Biological: Nivolumab Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Chondrosarcoma | Leiomyosarcoma | Liposarcoma | Research | Sarcomas | Soft Tissue Sarcoma | Yervoy